Marijuana's Impact on Alcohol Motivation and Consumption
NCT ID: NCT02983773
Last Updated: 2021-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
131 participants
INTERVENTIONAL
2017-01-23
2021-07-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cannabis' Impact on Alcohol Consumption
NCT05389930
Alcohol and Cannabis Concentrates Co-Administration
NCT05999344
Cannabinoid Receptor Function & Alcoholism
NCT00624715
Responsible Marijuana Sales Practices to Reduce the Risk of Selling to Intoxicated Customers
NCT06235632
Alcohol and Cannabis Co-Use and the Gut-Brain Axis
NCT04998006
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High THC dose
1 marijuana cigarette (7.2% THC)
THC 7.2%
1 smoked marijuana cigarette with 7.2% THC
Low THC dose
1 marijuana cigarette (3.0% THC)
THC 3.0%
1 smoked marijuana cigarette with 3.0% THC
Placebo
Placebo marijuana cigarette
Placebo
1 smoked placebo marijuana cigarette
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
THC 7.2%
1 smoked marijuana cigarette with 7.2% THC
THC 3.0%
1 smoked marijuana cigarette with 3.0% THC
Placebo
1 smoked placebo marijuana cigarette
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English-speaking
* marijuana smoking in past month
* report of current heavy episodic (binge) drinking
* in good physical health and weighing \< 250 lbs
* zero breath alcohol at each visit
Exclusion Criteria
* smoking \>20 tobacco cigarettes per day
* positive pregnancy test
* nursing
* positive urine toxicology screen for drugs other than cannabis
* interest to quit or receive treatment for marijuana or alcohol use
* meeting criteria for a current affective disorder (depression, or mania, panic disorder, and having psychotic symptoms as assessed by the SCID)
21 Years
44 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
Brown University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jane Metrik
Associate Professor (research)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jane Metrik, PhD
Role: PRINCIPAL_INVESTIGATOR
Brown University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brown University
Providence, Rhode Island, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1511001372
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.